The American Pharmacists Association is reminding the 250 million people who visit the pharmacy each week to utilize their relationship with their neighborhood pharmacist to meet their health care and information needs during the cold and flu season.
UnitedHealthcare has announced the winners of the second annual UnitedHealthcare Medication Adherence Targeted Intervention Program Challenge benefiting the National Association of Chain Drug Stores Foundation.
Dr. Reddy’s Laboratories announced Tuesday that it has launched Valganciclovir Tablets USP 450 mg, a therapeutic equivalent generic version of the antiviral Valcyte (Valganciclovir) tablets, in the U.S. market.
The CVS Health Research Institute released a first look at the comparative utilization of two new hepatitis C treatments in the weeks following their respective launches.
Iodine, developer of health information website Iodine.com, on Wednesday launched a new Web app for cold and flu season.
Rite Aid on Thursday reported fiscal third-quarter revenues of $6.7 billion, an increase of 5.3%, driven primarily by same-store sales, the drug store retailer said.
CVS has developed an omnichannel strategy for this holiday season. The retailer is focused on targeting customers online, on mobile and in stores.
Google could be preparing to take on Amazon.com with its own unique e-commerce solution.
The Food and Drug Administration on Wednesday approved Xtoro (finafloxacin otic suspension), a new drug that's used to treat acute otitis externa, commonly known as swimmer's ear.
PL Developments on Wednesday announced that it has added menopause relief supplement, EstroG-100, to its private-label portfolio.